Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Do GLP 1 & GIP Based Therapies reduce appetite
(4) critical risk of bias
Although these drugs are FDA-approved to treat specific conditions, such as obesity or type 2 diabetes, research studies for potential additional uses and conditions, beyond obesity and diabetes, are underway
Consult the provider or a doctor for guidance
Found Health's telehealth weight loss platform has seen increased consumer interest from consumers researching GLP-1 medication access, insurance coverage pathways, and program pricing in 2026
US$ 24.55
US$ 21.17
US$ 23.15
US$ 20.55
